ID: ALA5283910

Max Phase: Preclinical

Molecular Formula: C55H95N5O15

Molecular Weight: 1066.38

Associated Items:

Representations

Canonical SMILES:  CCCCC[C@@H]1OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C(=O)[C@H](CCCCC)OC(=O)[C@@H](C)N(C)C1=O

Standard InChI:  InChI=1S/C55H95N5O15/c1-16-21-26-31-41-46(61)56(11)37(7)52(67)72-43(33-28-23-18-3)48(63)58(13)39(9)54(69)74-45(35-30-25-20-5)50(65)60(15)40(10)55(70)75-44(34-29-24-19-4)49(64)59(14)38(8)53(68)73-42(32-27-22-17-2)47(62)57(12)36(6)51(66)71-41/h36-45H,16-35H2,1-15H3/t36-,37-,38-,39-,40-,41+,42+,43+,44+,45+/m1/s1

Standard InChI Key:  LXXQZAAILPIHSY-XQZCZENMSA-N

Associated Targets(non-human)

Ryanodine receptor 2 21 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1066.38Molecular Weight (Monoisotopic): 1065.6825AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Smith AN, Blackwell DJ, Knollmann BC, Johnston JN..  (2021)  Ring Size as an Independent Variable in Cyclooligomeric Depsipeptide Antiarrhythmic Activity.,  12  (12.0): [PMID:34917258] [10.1021/acsmedchemlett.1c00508]

Source